Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2020 2020-12-04
Next Day Disclosure Return 2020-11-17
VOLUNTARY ANNOUNCEMENT - ABSTRACTS ON PRELIMINARY POSITIVE RESULTS FROM THE COMBINATION THERAPY OF KN026 AND KN046 FOR POSTER PRESENTATION AT SITC 2020 2020-11-10
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020 2020-11-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2020 2020-10-08
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2020 2020-09-04
VOLUNTARY ANNOUNCEMENT - KN046 WAS GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA 2020-09-03
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2020 2020-08-28
DATE OF BOARD MEETING 2020-08-18
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2020 2020-08-06

20 21 22 23 24 25 26